Open Angle Glaucoma Market Report (2023-2033): Epidemiology, Industry Trends, Share, Size, Demand

 

IMARC Group has recently released a report titled “Open Angle Glaucoma Market: Analysis of Epidemiology, Industry Trends, Size, Share, and Future Forecast (2023-2033)” that presents a comprehensive assessment of the open angle glaucoma market size. The report provides an extensive overview of the latest market trends, growth prospects, investment opportunities, and industry outlook, as well as an in-depth analysis of the disease landscape, market scenario, and growth trends. Furthermore, the report offers an analysis of competitors, regional markets, and recent advancements in the global market. It also sheds light on crucial segments and market drivers, along with challenges faced by industry players. This report is a valuable resource for stakeholders who want to gain valuable insights into the open angle glaucoma market.

Open angle glaucoma is a chronic, irreversible, and progressive multifactorial optic neuropathy in which the pressure inside the eye increases. It is marked by a rise in intraocular pressure, an open angle of the anterior chamber, alterations to the optic nerve head, and a gradual loss of peripheral vision, followed by the loss of the central visual field. Some of the common indications of this ailment include blurred eyesight, eye pain, redness in the white of the eye, a swollen or bulging cornea, rainbow-colored halos around lights, nausea, vomiting, headaches, etc. The diagnosis of open angle glaucoma involves the evaluation of the patient’s clinical features, medical history, and eye examination. Several other assessments, such as a slit-lamp exam, gonioscopy, and optical coherence tomography, are also conducted.

Request a Free Sample Report: https://www.imarcgroup.com/open-angle-glaucoma-market/requestsample

The growing prevalence of eye disorders, which increase resistance in the drainage canals and damage the optic nerve, is primarily driving the open angle glaucoma market. Apart from this, the rising cases of various associated risk factors, including advanced age, family history, obesity, diabetes, hypertension, etc., are also contributing to the market growth. Moreover, the escalating utilization of effective drugs, such as alpha-2 adrenergic agonists and carbonic anhydrase inhibitors, which lower aqueous production, improve uveoscleral outflow, and help manage the condition, is providing a positive outlook for the market. Besides this, the rising preference for less invasive glaucoma surgery (MIGS), on account of its numerous advantages, including the better removal of fluid from the eye and a fast recovery pace with potentially fewer side effects than conventional surgeries, is anticipated to propel the open angle glaucoma market in the coming years.

Report Period:

• Base Year: 2022
• Historical Period: 2017-2022
• Market Forecast: 2023-2033

Countries Included:

• United States
• Germany
• France
• United Kingdom
• Italy
• Spain
• Japan

Analysis Covered Across Each Country

• Historical, current, and future epidemiology scenario
• Historical, current, and future performance of the open angle glaucoma market
• Historical, current, and future performance of various therapeutic categories in the market
• Sales of various drugs across the open angle glaucoma market
• Reimbursement scenario in the market
• In-market and pipeline drugs

In-Market Drugs

• Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Drug Uptake and Market Performance

Late-Stage Pipeline Drugs

• Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Regulatory Status

Ask an Analyst for Report Customization with TOC & List of figures: https://www.imarcgroup.com/request?type=report&id=7383&flag=C

Key Questions Answered in this Report:

• How has the open angle glaucoma market performed so far and how will it perform in the coming years?
• What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?
• What was the country-wise size of the open angle glaucoma market across the seven major markets in 2022 and what will it look like in 2033?
• What is the growth rate of the open angle glaucoma market across the seven major markets and what will be the expected growth over the next ten years?
• What are the key unmet needs in the market?

Browse the Latest Research Report:

Chronic Sialorrhea Market

Chronic Lymphocytic Leukemia Market

Calciphylaxis Market

Cardiotoxicity Market

About Us: –

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-08